Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-02 3:08 pm Purchase | 2023-02-02 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Invesco Ltd. IVZ | 2,207,649 5.300% | 140,293 (+6.79%) | Filing History |
| 2023-01-31 4:00 pm Purchase | 2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Medicxi Growth I LP | 2,484,274 6.000% | 416,413 (+20.14%) | Filing History |
| 2022-09-26 4:00 pm Purchase | 2022-09-22 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences IX L.P. | 8,424,772 21.500% | 203,448 (+2.47%) | Filing History |
| 2022-09-23 5:15 pm Purchase | 2022-09-22 | 13G | Phathom Pharmaceuticals, Inc. PHAT | James E. Flynn | 2,414,897 5.810% | 2,414,897 (New Position) | Filing History |
| 2022-08-11 3:55 pm Purchase | 2022-08-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences IX L.P. | 8,221,324 21.000% | 2,377,400 (+40.68%) | Filing History |
| 2022-05-16 4:32 pm Sale | 2022-05-16 | 13G | Phathom Pharmaceuticals, Inc. PHAT | RA Capital Management, L.P. | 0 0.000% | -3,115,008 (Position Closed) | Filing History |
| 2022-02-14 4:11 pm Sale | 2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | RA Capital Management, L.P. | 3,115,008 9.900% | -710,000 (-18.56%) | Filing History |
| 2022-02-11 6:16 pm Purchase | 2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Avidity Partners Management LP | 1,896,000 6.000% | 1,896,000 (New Position) | Filing History |
| 2022-02-10 4:54 pm Sale | 2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | JANUS HENDERSON GROUP PLC JHG | 1,841,357 5.900% | -97,079 (-5.01%) | Filing History |
| 2022-02-10 4:16 pm Sale | 2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Yamada Tadataka | 0 0.000% | -1,687,721 (Position Closed) | Filing History |
| 2022-02-10 11:32 am Purchase | 2022-02-09 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Invesco Ltd. IVZ | 2,067,356 6.600% | 12,918 (+0.63%) | Filing History |
| 2022-02-10 08:32 am Purchase | 2021-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | The Vanguard Group | 1,927,844 6.140% | 1,927,844 (New Position) | Filing History |
| 2021-11-12 06:03 am Sale | 2021-11-09 | 13D | Phathom Pharmaceuticals, Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD | 7,459,304 19.200% | -1,212,696 (-13.98%) | Filing History |
| 2021-04-06 06:05 am Unchanged | 2021-04-02 | 13D | Phathom Pharmaceuticals, Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD | 8,672,000 22.300% | 0 (Unchanged) | Filing History |
| 2021-04-01 06:06 am Unchanged | 2021-03-31 | 13D | Phathom Pharmaceuticals, Inc. PHAT | TAKEDA PHARMACEUTICAL CO LTD | 8,672,000 22.300% | 0 (Unchanged) | Filing History |
| 2021-02-16 4:39 pm Purchase | 2020-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | RA Capital Management, L.P. | 3,825,008 12.300% | 178,200 (+4.89%) | Filing History |
| 2021-02-12 2:53 pm Sale | 2021-02-12 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Invesco Ltd. IVZ | 2,054,438 6.600% | -47,865 (-2.28%) | Filing History |
| 2021-02-11 5:05 pm Purchase | 2020-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | JANUS HENDERSON GROUP PLC JHG | 1,938,436 6.700% | 470,974 (+32.09%) | Filing History |
| 2021-02-11 4:15 pm Sale | 2020-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Socks David A | 1,505,945 4.800% | -180,759 (-10.72%) | Filing History |
| 2021-02-11 4:15 pm Purchase | 2020-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT | Yamada Tadataka | 1,687,721 5.400% | 1,017 (+0.06%) | Filing History |